Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Monthly Archives: April 2020
Private Enterprise Continues to Flatten the Curve
Raymond March
-
April 28, 2020
0
Governments Can’t Plan Economy’s Reopening
Benjamin Powell
-
April 18, 2020
0
Economy Prosperity or Pandemic Protection: Why Not Both?
Raymond March
-
April 15, 2020
0
Cut Regulations and Get COVID-19 Drugs to Patients
Raymond March
-
April 8, 2020
0
Drug Is Safe and Sometimes Works, Let All COVID-19 Patients Take...
Ronald L. Trowbridge
-
April 2, 2020
0
Right-to-Try Laws Can Help Drugmakers Combat the Coronavirus
Raymond March
-
April 1, 2020
0
Edit with Live CSS
